De klinisk relevante CTC- toksiciteter, som blev rapporteret hos < 1% (ikke almindelig) af de patienter, der var randomiseret til pemetrexed, omfattede supraventrikulær arytmi.
Clinically relevant CTC toxicities that were reported in < 1% (uncommon) of the patients that were randomly assigned to pemetrexed include supraventricular arrhythmias.